相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nocebo effects can make you feel pain
Luana Colloca
SCIENCE (2017)
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials
Bret R. Rutherford et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25-50 mg/day) and escitalopram (10-20 mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study
T. Udristoiu et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
The nocebo effect of drugs
Sara Planes et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study
Gang Wang et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Nocebo Effects in the Treatment of Major Depression: Results From an Individual Study Participant-Level Meta-Analysis of the Placebo Arm of Duloxetine Clinical Trials
Seetal Dodd et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice
Manfred Schedlowski et al.
PHARMACOLOGICAL REVIEWS (2015)
The Role of Patient Expectancy in Placebo and Nocebo Effects in Antidepressant Trials
Bret R. Rutherford et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
Angelo Sambunaris et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Nocebo effect in randomized clinical trials of antidepressants in children and adolescents: systematic review and meta-analysis
Johanna Carolina Rojas-Mirquez et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Comparable efficacy and safety of 8 weeks treatment with agomelatine 25-50 mg or fluoxetine 20-40 mg in Asian out-patients with major depressive disorder
L. Shu et al.
ASIAN JOURNAL OF PSYCHIATRY (2014)
The nocebo effect: A clinicians guide
Joao Data-Franco et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder
Rakesh Jain et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
Stuart A. Montgomery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Sponsorship, Antidepressant Dose, and Outcome in Major Depressive Disorder
Mark Sinyor et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Closing the Gap between Methodologists and End-Users: R as a Computational Back-End
Byron C. Wallace et al.
JOURNAL OF STATISTICAL SOFTWARE (2012)
Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study
Paula J. Gaynor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder
Arif Khan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Symptomatic and Functional Improvement in Employed Depressed Patients A Double-Blind Clinical Trial of Desvenlafaxine Versus Placebo
Boadie W. Dunlop et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Faster Onset of Antidepressant Effects of Citalopram Compared With Sertraline in Drug-Naive First-Episode Major Depressive Disorder in a Chinese Population A 6-Week Double-Blind, Randomized Comparative Study
Ju-Wei Hsu et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline
Siegfried Kasper et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials? Results From Pooled and Meta-Analyses
Mark Sinyor et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Karen Hewett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome
Bret R. Rutherford et al.
CURRENT PSYCHIATRY REVIEWS (2010)
Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: An 8-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial and a Post Hoc Pooled Analysis of Three Studies
Karen A. Tourian et al.
CLINICAL THERAPEUTICS (2009)
A Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible-Dose Desvenlafaxine Treatment in Outpatients with Major Depressive Disorder
Alan D. Feiger et al.
CNS SPECTRUMS (2009)
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
K. Hewett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Escitalopram in major depressive disorder: A multicenter, randomized, double-blind, flxed-dose, parallel trial in a Chinese population
Pei-xian Mao et al.
DEPRESSION AND ANXIETY (2008)
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor
Alan J. Lenox-Smith et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder
Michael R. Liebowitz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
Jean Pierre Olie et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil
Phil Lee et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2007)
Nocebo effects with antidepressant clinical drug trial placebos
Roy R. Reeves et al.
GENERAL HOSPITAL PSYCHIATRY (2007)
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
Andrew A. Nierenberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder
Arif Khan et al.
CLINICAL DRUG INVESTIGATION (2007)
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder
Richard C. Shelton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Selegiline transdermal system for the treatment of major depressive disorder: An 8-week, double-blind, placebo-controlled, flexible-dose titration trial
Alan D. Feiger et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder
C. Munizza et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: Findings from a randomized, double-blind, placebo-controlled study
James W. Jefferson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
SH Kennedy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression
MS Lee et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder
S Kasper et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
N Moore et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Patient expectations in placebo-controlled randomized clinical trials
DA Stone et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2005)
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients
M Versiani et al.
CNS DRUGS (2005)
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder
RJ Bielski et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant
HV Krell et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder
SA Montgomery et al.
NEUROPSYCHOBIOLOGY (2004)
Mirtazapine orally disintegrating tablet versus sertraline:: A prospective onset of action study
K Behnke et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients
CJ Hong et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder
JD Amsterdam
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Transdermal selegiline in major depression: A double-blind, placebo-controlled, parallel-group study in outpatients
JA Bodkin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety
A De Nayer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care
A Wade et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Nonspecific medication side effects and the nocebo phenomenon
AJ Barsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial
E Sacchetti et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2002)
The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action
M Versiani
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2000)
Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression
HJ Möller et al.
PHARMACOPSYCHIATRY (2000)
Mirtazapine compared with paroxetine in major depression
O Benkert et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Gender differences in treatment response to sertraline versus imipramine in chronic depression
SG Kornstein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia
V Gentil et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
分享论文
